Dekiln & Johnson Tiles partner to scale green tile technology

About this episode

Dekiln partners with Johnson Tiles to develop a bio-based alternative to ceramic tiles, reducing energy costs and carbon footprint.

Dekiln, a Frontier IP Group PLC (LSE:FIPP, FRA:8WT) portfolio company, has partnered with Johnson Tiles to scale its bio-based alternative to ceramic tiles — a product CEO Dr Aled Roberts describes to Proactive's Stephen Gunnion as something that "looks, feels, behaves like a ceramic tile" but requires no kiln firing. "What we're offering is an alternative to conventional ceramics that doesn't need to be fired — much lower energy input costs, much lower carbon footprint," Roberts says. The timing is well chosen: rising energy costs have hit the UK ceramics industry hard, making a kiln-free alternative increasingly compelling. A £3 million Royal Academy of Engineering fellowship is backing a pilot plant in Stoke-on-Trent, which will use waste plaster of Paris from the pottery industry as a key raw material. Beyond tiles, Dekiln is also exploring sustainable alternatives to concrete. For more interviews and market insights, visit the Proactive YouTube channel, give this video a like, subscribe to the channel and enable notifications so you never miss future content. #Dekiln #FrontierIP #JohnsonTiles #SustainableTechnology #GreenConstruction #CeramicTiles #CleanTech #Biomimicry…

People in this episode

Host: Stephen Gunnion

Guest: Dr Aled Roberts

Topics covered

• sustainable technology
• green construction
• ceramic tiles
• clean tech
• low carbon

Keywords

• Dekiln
• Johnson Tiles
• sustainable alternatives
• ceramic tiles
• low carbon
• clean technology
• Stoke-on-Trent

Mentioned in this episode

Organizations: Dekiln, Johnson Tiles, Frontier IP Group PLC

Places: UK, Stoke-on-Trent

More episodes of Proactive - Interviews for investors

• Regan Capital CIO on bond market opportunities in a rising rate environment · June 12, 2026 · 6 min
• Light Science Technologies lifts capacity 50% with new SMT line and global client win · June 12, 2026 · 5 min
• Poolbeg Pharma launches POLB 001 TOPICAL trial to tackle CAR-T side effects · June 12, 2026 · 4 min
• Lumos Diagnostics expands FebriDx adoption across 100+ US healthcare sites with CLIA Waiver · June 11, 2026 · 8 min
• Flow Metals advances drill-ready Yukon gold project while expanding Copper exploration in B.C. · June 11, 2026 · 6 min
• Midstream energy sector positioned for growth as LNG and AI drive demand · June 11, 2026 · 7 min